posted December 13, 2021 08:05 am by willyk3
(67)
The obvious solution at this stage is to just sell the darn company (at a discount) to a real pharmaceautical company who has the capability to complete the process
rate and reply
posted December 09, 2021 09:46 am by willyk3
(67)
Absolute dud The fact that they failed at the manufacturing revisions shows that they and their mfg partner are incompetant at this aspect of the process. Wonder who that is ?
...read more
posted December 09, 2021 07:08 am by AviseAnalytics
(4)
$FENC Fennec Pharmaceuticals (NASDAQ:FENC), a "specialty pharmaceutical company", received a CRL from the FDA for its New Drug Application (NDA) for PEDMARK™ (sodium
...read more
posted September 27, 2021 05:30 pm by willyk3
(67)
Thats a heck of a spread on the bid ask? Has my machine gone bonkers?
rate and reply
posted June 22, 2021 08:13 am by willyk3
(67)
Resubmission is in! Is there anyone out there to notice? Guess we still have to hope that they dont fail....with the FDA I am never confident of anything. Buyout coming???
rate and reply
posted March 20, 2021 12:49 pm by willyk3
(67)
No news at all. Wonder whats up with that resubmission? Shouldnt financials be out for this quarter? I thought they were reasonably cashed up but lack of any communication from the company is
...read more
posted March 01, 2021 12:44 pm by neuralProphet
(4)
Not too may shares outstanding + less than avg 100k shares trading in CanadaUS in total = not enough retail owners to light up a Stockhouse board. Yahoo forum has a bit more action. Revenue wise
...read more
posted January 28, 2021 05:10 pm by stockfy
(83)
Any idea when FRX will report the first revenue? Just a rough estimate. Thanks.
rate and reply
posted January 28, 2021 05:09 pm by stockfy
(83)
Why is this board so silent? Aren't any retail investors in FRX?
rate and reply